Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ana Isabel

Ana Isabel Alonso Varona, Getxo ES

Patent application numberDescriptionPublished
20110256186 BIOMATERIAL BASED ON WHARTON'S JELLY FROM THE HUMAN UMBILICAL CORD - The present invention relates to a biomaterial, specifically a hydrogel, formed from the extracellular matrix of the umbilical cord for its application in regenerative medicine. The invention particularly relates to a biomaterial made up of glycosaminoglycans isolated exclusively from the Wharton's jelly of the umbilical cord which can optionally contain cells, and also to the methods for the production and use thereof.10-20-2011

Ana Isabel Fernandez Martinez, Murcia ES

Patent application numberDescriptionPublished
20100179060PURE CULTURE OF STRAIN AH2 OF THE BACILLUS VELEZENSIS SPECIES AND A PRODUCT FOR THE BIOLOGICAL CONTROL OF PHYTOPATHOGENIC FUNGI - The invention relates to a new fungicide product for the biological control of phytopathogenic fungi, which contains a new isolate of 07-15-2010
20110045976BIOLOGICAL FERTILIZER, METHOD FOR OBTAINING SAME AND USE THEREOF AS A PLANT GROWTH STIMULATOR - The invention relates to a novel biological fertiliser, a method for obtaining same and the use thereof as a plant growth stimulator, said fertiliser comprising a pure culture of strain C3 of Pantie dispersal, a pure culture of strain M3 of 02-24-2011

Ana Isabel Jimenez Anton, Madrid ES

Patent application numberDescriptionPublished
20090176728Treatment of CNS Conditions - Methods and compositions for the treatment of pathologic conditions of the central nervous system (CNS) by means of intranasal administration of a composition that modulates, by means of RNA interference, the expression and/or activity of genes involved in above-mentioned conditions.07-09-2009
20100286230MODULATION OF TRPV EXPRESSION LEVELS - The present invention relates to methods and compositions for the treatment and/or the prevention of conditions related to high levels of expression and/or activity of the transient receptor potential vanilloid-1 (TRPV1). Amongst others, the conditions to be treated are eye conditions such as discomfort and altered sensitivity of the cornea following refractive surgery, use of contact lenses, dry eyes and diabetic retinopathy.11-11-2010

Ana Isabel Mateo Herranz, Alcobendas-Madrid ES

Patent application numberDescriptionPublished
20100204207Compounds and Methods for Treating Dyslipidemia - Compounds of Formula (I): wherein n, m, p, q, Y, R1, R2, R3a, R3b, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed.08-12-2010

Patent applications by Ana Isabel Mateo Herranz, Alcobendas-Madrid ES

Ana Isabel Mateo Herranz, Madrid ES

Patent application numberDescriptionPublished
20080269284Compounds and Methods for Treating Dyslipidemia - Compounds of Formula I wherein n, q, Y, R10-30-2008
20100160340PROTEIN KINASE INHIBITORS - The present invention provides a compound of formula (I):06-24-2010

Patent applications by Ana Isabel Mateo Herranz, Madrid ES

Ana Isabel Perez-Neira, Castelldefels (barcelona) ES

Patent application numberDescriptionPublished
20100182967POWER ALLOCATION METHOD IN MULTIANTENNA SYSTEMS UNDER PARTIAL CHANNEL KNOWLEDGE - Method for allocating a minimum downlink power from a transmitter (07-22-2010
20100303002BEAMFORMING TECHNIQUE FOR BROADBAND SATELLITE COMMUNICATIONS - Method for assigning a precoding beam forming scheme in a broadband satellite system, wherein said broadband satellite system comprises a multibeam satellite (12-02-2010
20100329119METHOD OF EFFICIENT CHANNEL ALLOCATION IN WIRELESS SYSTEMS - Method of efficiently allocating a downlink channel from a transmitter (12-30-2010

Ana Isabel Vila Pena, Santiago De Compostela ES

Patent application numberDescriptionPublished
20090074824STABLE NANOCAPSULE SYSTEMS FOR THE ADMINISTRATION OF ACTIVE MOLECULES - The invention is aimed at nanocapsule systems characterized in that they have high stability during long periods of time. These systems are useful for the controlled release of pharmacologically or cosmetically active ingredients of highly lipophilic nature. The system comprises nanocapsules with an average size less than 1 μm dispersed in an aqueous medium, wherein the nanocapsules have a structure which comprises a lipophilic phase containing a phospholipid component and one or more saturated and/or unsaturated C03-19-2009
20110142890NANOPARTICLES OF CHITOSAN AND HYALURONAN FOR THE ADMINISTRATION OF ACTIVE MOLECULES - The present invention relates to a nanoparticulate system useful for the delivery of pharmacologically active molecules, and especially for transfecting polynucleotides into cells. It comprises nanoparticles of chitosan of low molecular weight and hyaluronan.06-16-2011

Ana Isabel Vila Pena, Santiago De Compestela ES

Patent application numberDescriptionPublished
20080317864Chitosan and Heparin Nanoparticles - The invention is aimed at nanoparticulate systems for the controlled release of heparin. It is specifically aimed at nanoparticulate systems comprising chitosan, heparin and optionally a polyoxyethylenated derivative, and which are ionically cross-linked, as well as being aimed at processes for obtaining them.12-25-2008